A Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine Clearance
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This open-label, prospective, single dose study will evaluate the pharmacokinetics and safety
of Tamiflu (oseltamivir) in volunteers on dialysis and in volunteers with a creatinine
clearance from 10 to 30 mL/min. Volunteers will receive a single oral dose of Tamiflu.